Pet Vaccines Market By Vaccine Type (Core Vaccines {Canine Parvovirus, Canine Distemper, Canine Adenovirus, Canine Parainfluenza, Feline Viral Rhinotracheitis, and Feline Panleukopenia}) and Non-Core Vaccines {Bordetella bronchiseptica, Lyme Disease, Leptospirosis, and Feline Leukemia Virus (FeLV)}), By Route of Administration (Injectable Vaccines, Oral Vaccines, and Intranasal Vaccines), By Pet Type (Dogs, Cats, Horses, and Others), and By Distribution Channels (Veterinary Clinics, Pet Stores, Online Retail, and Animal Hospitals), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Pet Vaccines market accounted for USD 10.85 Billion in 2024 and is expected to reach USD 24.0 Billion by 2035, growing at a CAGR of around 7.5% between 2025 and 2035. The pet vaccinations market includes the development, manufacture, and sale of vaccines designed for pets, with an emphasis on dogs and cats, to protect them from developing specific infectious diseases. This market has expanded due to the rising pet population, improved knowledge of pet health, and developments in veterinary science. Vaccines prevent various pet-specific ailments, such as rabies, parvovirus, and feline leukemia, which improve the pet's longevity and quality of life. However, the market is sensitive to a set of regulations, tendencies in pet insurance, and an increasing level of interest in preventive healthcare services. It is an essential part of the large spectrum of veterinary healthcare services.

Report Scope:

Market Dynamics

Growing awareness of pet health encourages preventive care practices.

The pet vaccinations market has profited immensely from increased awareness of pet health as pet owners have accepted the importance of vaccinating their dogs. This is attributed to rising disposable income, increased pet ownership, humanization of pets, and a broad recognition among pet owners that they must invest in their pets' health. Further, research in veterinary medicine and the development of varied vaccines assure market growth. According to the American Veterinary Medical Association (AVMA), over 84 million homes in the United States have pets, and vaccination is one of the most important things that pet owners think about for their animals. Moreover, today's social networks and pet wellness campaigns raise awareness of the availability and benefits of all vaccines, making the average customer savvier. Consequently, this rising awareness creates responsible pet adoptions and demands for new vaccines, thus making preventive care an important aspect of pet and public health.

Zoonotic disease outbreaks increase urgency for pet vaccinations.

Several factors influence the pet vaccines market, including increased awareness of zoonotic illnesses that are transmissible between animals and humans. Higher consciousness has resulted in increased uptake of regular checkups for your pets and has encouraged owners to have their pets vaccinated against various ailments. Furthermore, the expanding population of companion animals and the owners’ rising conviction that their pets are family members has boosted the demand for vaccinations to better these animals' lives. Another factor that fosters market growth is an increased understanding of veterinary medicine and the creation of better and more efficient vaccines. Government policies, increased knowledge of pet health, and the expansion of veterinary services over the Internet have all made vaccinations more accessible. These factors stress the significance of vaccination in improving the health of pets and preventing the threat of disease to the public.

Low awareness in rural areas hinders market penetration.

Poor awareness in the rural setting reduces market access for pet vaccines. People in these areas frequently catch up on vital knowledge about pet immunizations due to misconceptions and a lack of veterinary care. Rural areas have minimum organization and fewer veterinary units, making vaccination delivery challenging. The expense of vaccinations can be a concern in communities since pet owners in the regions can afford all parts of their pets' demands over preventive healthcare for their animals. Furthermore, cultural ideas and customs may influence attitudes about vaccination, making the outreach process more complicated. All these factors cumulatively limit the growth of the pet vaccine market in rural regions, thereby requiring distinct awareness-raising and resource-mobilization strategies.

The development of combination vaccines can attract more pet owners.

The growth in the use of combination vaccines is a significant opportunity in the pet vaccines market, as owners prefer variety-pack vaccines that are affordable and efficient for their pets. Such a form of vaccine as combos will enable veterinarians to administer several vaccines in one go, simplifying the vaccination process and making it less stressful for the pets and their owners. That approach helps to improve compliance with the schedules of vaccinations and contributes to the other benefits connected with the pets’ health.

With increasing awareness regarding preventive care, pet owners are willing to spend on products with sound health coverage against various diseases. Moreover, combination vaccines might be less expensive than single vaccines, so pet owners will find them affordable. The same is true for imbuing dogs with increasingly human features, which necessitates the employment of advanced veterinary care goods such as breakthrough vaccines. Consequently, as the worldwide market grows, organizations dedicated to the development of combination vaccines are anticipated to capture a larger share of this expanding market. There is a significant chance to grow market share for pet vaccines, and the use of combination vaccines is now a market trend.

Industry Experts Opinion

“Vaccines are remarkably safe and effective, and truly protect our beloved four-legged companions against significant, often fatal, diseases. The benefits far outweigh the risks, and each pet’s vaccine needs can be tailored to their specific risk for infection.”

• Mark Freeman, clinical associate professor of community practice at the Veterinary Teaching Hospital.

Segment Analysis

Based on the vaccine type, the Pet Vaccines market is classified into Core Vaccines and Non-Core Vaccines. In the pet vaccines market, core vaccines are dominant in the vaccine-type segment. These vaccines are important to prevent essential and dangerous diseases for pets, including rabies, distemper, parvovirus in dogs, and Feline viral rhinotracheitis and panleukopenia in cats. This is due to legal necessities and the rising knowledge of owners about the preventive health of their pets. Such a trade is essential due to legal requirements and owners' increasing awareness of their pets' preventive health. There is a market predominance of core vaccines, as these preparations are considered mandatory in veterinary medicine.

Based on the route of administration, the Pet vaccines market is classified into Injectable Vaccines, Oral Vaccines, and Intranasal Vaccines. Injectable vaccines are dominant in the route of administration segment of the pet vaccines market. They are usually employed because the vaccines exhibit effectiveness and a quick immune reaction, which makes them the go-to for basic vaccinations on dogs and cats. Injectable vaccines are versatile, protecting against a variety of diseases such as rabies, parvovirus, and distemper. Furthermore, they have been in practice for many years, notably in veterinary practice, and thus instill confidence in both clients and veterinarians. Injectable vaccines remain popular due to their convenience, dependability, and broad protection compared to orally administered or nasal drop-in vaccines. This is an important indication of the role of injectable vaccines in the health of pets, controlling and preventing epidemics.

Regional Analysis

In the pet vaccines market, North America is the leading region due to the development of pet ownership rates and the concern about animal health. The objective of key players is to develop more innovative vaccines with the consideration of providing for emerging situations that target cats and dogs. It is driven by rising veterinarian care costs and the growing significance of regular pet health examinations. Furthermore, increasing the quantity and coverage of veterinary clinics and mobile veterinary services boosts immunization capacity. This area is dynamic due to effective regulatory support and developments in vaccine technology, stressing safety and effectiveness. Overall, a broad view of North America shows vibrant vectoristic effects that improve pet health.

The pet vaccines market in Europe is highly focused on disease prevention and control due to the rising trend in the number of pet owners and growing concern with animal health. The regulatory settings around vaccine use in the region encourage a rigorous vaccine research, development, and approval procedure. Furthermore, as the incidence of zoonotic diseases and associated diseases rises, so does the number of pet care facilities and the trend of insurance coverage, which explains why immunization is easily accessible. There is an increased call for vaccination campaigns. Pharmaceutical companies are working with veterinary clinics to increase access to their product. The consumers’ demand for value-added products influences the developments in the market by promoting comprehensive pet care solutions. The European market is showing a continuously increasing concern for pets’ health and welfare.

Competitive Landscape

The pet vaccines market is concentrated and intensive in growth enabled by the core players, including Zoetis Inc., Merck Animal Health, and Boehringer Ingelheim. All these firms are seeking to improve their various products. For instance, Zoetis developed a new vaccine for canine influenza, creating new opportunities for the company to combat new diseases. Similarly, Merck Animal Health's core vaccination for dogs has recently been modified to increase its effectiveness against core diseases. Furthermore, Elanco and Virbac are working to develop single-shot vaccines that will minimize immunization schedules for pet owners. This market is active and competitive as a result of continual vaccine innovation, along with the formation of new alliances and mergers.

Pet Vaccines Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In March 2024, Petco Love's National Pet Vaccination Month highlights the critical importance of vaccinating pets to protect their health and wellbeing. The initiative aims to raise awareness about preventable diseases, urging pet owners to take proactive steps in safeguarding their furry companions through vaccinations.
• In January 2024, Boehringer Ingelheim officially launched Vaxxilive Cocci 3, a chicken coccidiosis vaccine that was previously known as Hatchpak Cocci III. The vaccination is used to prevent coccidiosis among birds.
• In July 2023, Kansas State University's College of Veterinary Medicine established a new Center on Vaccine Evaluation and Alternatives for Antimicrobials (CVEAA) to promote the development and use of animal vaccines.

Report Coverage:

By Vaccine Types

• Core Vaccines
  • Canine Parvovirus
  • Canine Distemper
  • Canine Adenovirus
  • Canine Parainfluenza
  • Feline Viral Rhinotracheitis
  • Feline Panleukopenia
• Non-Core Vaccines
  • Bordetella Bronchiseptica
  • Lyme Disease
  • Leptospirosis
  • Feline Leukemia Virus (FeLV)

By Route of Administration

• Injectable Vaccines
• Oral Vaccines
• Intranasal Vaccines

By Pet Type

• Dogs
• Cats
• Horses
• Others

By Distribution Channels

• Veterinary Clinics
• Pet Stores
• Online Retail
• Animal Hospitals

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Zoetis Inc.
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Virbac
• Ceva Santé Animale
• Heska Corporation
• Vetoquinol S.A.
• Pfizer Animal Health
• Merial
• IDEXX Laboratories
• Neogen Corporation
• Genus plc
• Novartis Animal Health
• Aratana Therapeutics

Frequently Asked Questions (FAQs)